MOUNTAIN VIEW, Calif., Oct. 22 /PRNewswire/ -- Complete Genomics Inc., a newly launched, third-generation human genome sequencing company, today announced the company's presentation at the 7th Annual BIO Investor Forum, which will be held in San Francisco, Oct. 29-31, 2008.
Dr. Clifford Reid, chairman, president and chief executive officer of Complete Genomics, will present on Wednesday, Oct. 29, at 2:45 p.m. in the Marina Room of the Palace Hotel, located at 2 New Montgomery Street in downtown San Francisco. He will discuss how Complete Genomics' scalable service model and proprietary technology advances will allow the company to introduce its sequencing service in Q2 2009 at a cost of $5,000 per genome.
About Complete Genomics
Founded in 2006, Complete Genomics is a California company that has developed a novel approach to sequencing human DNA. Complete Genomics plans to combine its proprietary third-generation DNA sequencing technology and its high-performance computing capabilities to create a human genome sequencing service that will deliver low-cost, high-quality data on an unprecedented scale. The company is currently building the world's largest human genome sequencing center. This development will allow pharmaceutical and biotechnology customers, for the first time, to conduct large-scale human genome studies that will help identify the genetic underpinnings of complex diseases and drug responses. For additional information about the company, please visit http://www.completegenomics.com.
CONTACT: Jennifer Turcotte, Vice President, Marketing of Complete Genomics
Inc., +1-650-943-2846, jturcotte@completegenomics.com; or Lisa Osborne,
Account Director of Waggener Edstrom Worldwide Healthcare, +1-202-261-7806,
lisao@waggeneredstrom.com, for Complete Genomics Inc.
Web site: http://www.completegenomics.com/
